WN
MDXG icon

Williams & Novak’s MiMedx Group MDXG Stock Holding History

Williams & Novak’s Portfolio MDXG Stock Details MDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$53.5K Buy
+13,884
New +$50.7K 0.04% 137

Other funds holding MDXG

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Williams & Novak's MDXG Position: Q2 2026 in Review

Williams & Novak opened a new position in MiMedx Group (MDXG) in Q2 2026: 13,884 shares worth $53.5K. The stake represents 0.04% of the portfolio and ranks #137 among its holdings.

226 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.

  • Williams & Novak held 13,884 shares of MiMedx Group worth $53.5K as of Q2 2026.
  • MiMedx Group was a new Williams & Novak position in Q2 2026.
  • MiMedx Group made up 0.04% of Williams & Novak's portfolio in Q2 2026, its #137 holding.
  • 226 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.

Based on Williams & Novak's 13F filing for Q2 2026, filed 8 Jul 2026.